Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs
Senior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address
Head of Life Sciences - London Lead Londons life sciences growth agenda London has one of the worlds strongest life sciences ecosystems, with recognised strengths in research, healthcare, clinical innovation, investment and entrepreneurship. London & Partners